CRT announces license agreement with MSD to develop inhibitors of PRMT5 for cancer and blood disorders
Cancer Research Technology (CRT) – the development and commercialisation arm of Cancer Research UK – has…
Browsing: chronic lymphocytic leukaemia(CLL)